Promotes Healthy Bone Remodeling in Postmenopausal Women* with Selective Kinase Response Modulators
Products are available through Authorized Metagenics Practitioners. If you have a Metagenics Practitioner Code, enter it in the Practitioner Code box next to the cart to continue shopping.
In a clinical study of postmenopausal women with low estrogen levels, Ostera™—in conjunction with a modified Mediterranean, low glycemic diet and regular exercise—was shown to beneficially influence key markers of bone remodeling more than diet and exercise alone. Bone remodeling is the natural process of healthy breakdown and formation of the bone matrix—the structure where minerals are deposited. This scientifically advanced formula features selective kinase response modulators (SKRMs) in the form of RIAA, as well as the herb berberine, and vitamins D and K to nutritionally support healthy bone remodeling during the aging process. Recommended for use with Cal Apatite®—an advanced bioactive formulation for bone mineralization.*
- Promotes healthy bone remodeling biomarkers to support bone quality and integrity.*
Clinically shown in a study of postmenopausal women with low estrogen levels to:*
- Beneficially influence key markers of bone remodeling.
- Positively influence osteocalcin, a key marker of bone remodeling rate.
- Offer more effectiveness than diet and exercise alone.
- Features selective kinase response modulators (SKRMs) in the form of RIAA from hops, as well as the herb berberine, and vitamins D and K to nutritionally support healthy bone remodeling during the aging process.*
- No reported serious adverse effects.
|Vitamin D (as cholecalciferol)||500 IU||125%|
|Vitamin K (as phytonadione)||500 mcg||625%|
|Berberine HCl (Phellodendron amurense bark extract)||90 mg||*|
|Reduced Iso-Alpha Acids Complex (from hops extract, Humulus lupulus L.)||370 mg||*|
Other Ingredients: Microcrystalline cellulose, stearic acid (vegetable), croscarmellose sodium, calcium silicate, silica, and coating (water, hypromelose, medium chain triglycerides , and hydroxyproylcellulose).
Directions: Take one tablet twice daily, or as directed by your healthcare practitioner.
This product is Gluten Free.
Warning: Do not use if pregnant or nursing or if taking cyclo-sporine or anticoagulant medication.
Caution: If taking other medication, consult your healthcare practitioner before use. Keep out of the reach of children.
Storage: Keep tightly closed in a cool, dry place.
Q.How does Ostera® compare to other products or approaches?
As a nutraceutical , this product is formulated to complement diet and exercise recommendations to promote bone health, but varies significantly from common bone health formulas that contain calcium. This product is intended as a complement to (not a substitute for) supplemental calcium recommendations. Ostera offers an approach for a unique target in postmenopausal bone health support, and may be the only nutritional supplement specifically designed to support healthy bone remodeling.*
Q.How does Ostera® work?
This product contains a science-based blend of ingredients to promote healthy bone remodeling, which supports the bone architecture that holds calcium and other minerals. Bone is living tissue, and the remodeling process helps remove old or damaged tissue and build new tissue. This process slows down with age and can also be influenced by estrogen decline in menopause and a subtle increase (associated with age or unhealthy lifestyle patterns) in cytokines that signal various body activities. Cellular studies showed that the RIAA in Ostera acts as a selective kinase (specialized enzyme) response modulator (SKRM) in signaling processes in the body related to bone health. (Balanced kinase signaling helps to maintain healthy function, and SKRMs can enhance "healthy" signals from a targeted dietary plan.) Berberine and vitamins D and K also help nutritionally support healthy bone remodeling during the aging process.*
Q.How long is Ostera® typically recommended?
This formula was designed for daily support of healthy bone remodeling—a continual process that influences the quality of bone structure. In a 12-week study at the FMRC, the Ostera program (including a low-glycemic-load diet and regular exercise) was shown to be more effective than diet and exercise alone in positively influencing markers of bone remodeling in postmenopausal women with low estrogen levels. Individual results may vary. Your health care professional may recommend regular follow-up visits to re-evaluate markers of bone health. For best results, follow your health care professional's guidelines.*
Q.Who would benefit from Ostera®?
Health care professionals typically recommend this product to postmenopausal women as part of a more comprehensive bone health program, specifically to promote healthy bone remodeling and support the integrity (quality) of the bone matrix (the architecture where minerals are deposited). This product may also be recommended for men or women prior to menopause, where appropriate. This product is not intended as a substitute for bone mineralization (density) support, such as MCHC calcium.*
Q.Why is Ostera® safe?
It contains a blend of natural ingredients with an excellent safety profile. Plus, Metagenics' manufacturing facility has 3 certifications for good manufacturing practices to ensure the highest quality. Key active ingredients in this formula were developed through the ExpresSyn Process® that sets a new standard in clinical certainty for natural products via demonstrated efficacy, bioavailability , and a high level of predicted safety. Ostera has been clinically reviewed at the FMRC. (This product is not recommended for those taking anticoagulant medications.)